H100 Group (H100) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
19 Aug, 2026Executive summary
Net sales for Q2 2026 were 2.9 MSEK, nearly flat year-over-year; H1 2026 net sales were 5.8 MSEK, unchanged from H1 2025.
Operating loss for Q2 2026 was -88.7 MSEK, with most of the loss due to non-cash impairment on Bitcoin holdings; H1 2026 operating loss was -234.6 MSEK.
Major post-period event: acquisition of NSD AS and Moonshot AS, increasing Bitcoin holdings to 3,506.4 BTC and resulting in a significant change in control and capital structure.
New CEO and CIO appointed in August 2026, reflecting a strategic shift and leadership transition.
Financial highlights
Q2 2026 net sales: 2.9 MSEK (Q2 2025: 3.0 MSEK); H1 2026 net sales: 5.8 MSEK (H1 2025: 5.8 MSEK).
Q2 2026 operating loss (EBIT): -88.7 MSEK (Q2 2025: -11.5 MSEK); H1 2026: -234.6 MSEK (H1 2025: -14.5 MSEK).
Q2 2026 loss before tax: -98.2 MSEK (Q2 2025: -23.4 MSEK); H1 2026: -253.6 MSEK (H1 2025: -26.5 MSEK).
Q2 2026 EPS: -0.29 SEK (Q2 2025: -0.20 SEK); H1 2026 EPS: -0.75 SEK (H1 2025: -0.25 SEK).
Cash and cash equivalents at June 30, 2026: 18.1 MSEK (June 30, 2025: 198.5 MSEK).
Outlook and guidance
No forecasts provided for future periods.
Strategic focus on disciplined capital allocation, Bitcoin as hurdle rate, and value creation beyond BTC holdings.
Latest events from H100 Group
- Scalable health tech platform leverages network effects and influencer distribution for rapid growth.H100
Status update - Strategic acquisitions will triple bitcoin holdings and strengthen the group's financial position.H100
Q1 2026 - Strategic shift to Bitcoin treasury drove rapid asset growth but resulted in large non-cash losses.H100
H2 25/26 - Strong sales growth and Bitcoin accumulation, but significant non-cash losses and volatility.H100
H1 25/26 - Revenue up 166%, net loss reduced, and strategic shift to digital health acquisition underway.H100
H1 24/25 - Annual loss deepened on portfolio write-downs; net asset value per share fell 22%.H100
H2 23/24 - Acquisition-driven transformation and capital infusion position H100 for digital health growth.H100
H2 24/25 - Accelerating Bitcoin Treasury and global health initiatives to empower sovereign individuals.H100
Status update